SECsense Logo

Aquestive Therapeutics 8-K Report: Key Insights on January 13, 2025 Developments

$AQST
Form 8-K
Filed on: 2025-01-13
Source
Aquestive Therapeutics 8-K Report: Key Insights on January 13, 2025 Developments

Based on the provided XML data from the financial report, here are the key insights extracted:

  1. Company Information:
  • Name: Aquestive Therapeutics, Inc.
  • Location: 30 Technology Drive, Warren, NJ 07059
  • Phone Number: 908-941-1900
  1. SEC Filing Details:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: January 13, 2025
  • CIK Number: 0001398733
  • IRS Employer Identification Number (EIN): 82-3827296
  1. Company Structure:
  • State of Incorporation: Delaware (DE)
  • SEC Central Index Key (CIK): 0001398733
  • NASDAQ Symbol: AQST
  • Common Stock Par Value: $0.001 per share
  1. Reporting Period:
  • Start Date: January 13, 2025
  • End Date: January 13, 2025

This data indicates that the filing is likely related to a significant event or change occurring on January 13, 2025, for Aquestive Therapeutics, which could impact its stock and market position. The 8-K filing type indicates that the information disclosed is essential for investors and stakeholders to be aware of potential changes or developments affecting the company.